Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36554 Ocular Therapeutix, Inc. (Exact name of registrant as specified in its charter) Delaware 20-5560161 (St ...

( N A S D AQ: O C U L ) TRANSFORMING DRUG DELIVERY LEVERAGING A NOVEL TECHNOLOGY PLATFORM MICHAEL GOLDSTEIN, M.D., M.B.A. CHIEF MEDICAL OFFICER MARCH 2019 FORWARD LOOKING STATEMENTS Any statements in this presentation about future expectations, plans and prospects for the Company, including the commercialization of DEXTENZA®, ReSure Sealant, or any of the Company's product candidates, development and regulatory status of the Company's product candidates, such as the Company's anticipated commercial launch o ...

Ocular Therapeutix (NASDAQ:OCUL) Q4 2018 Earnings Conference Call March 7, 2019 4:30 PM ET Company Participants Antony Mattessich - President and Chief Executive Officer Donald Notman - Chief Financial Officer Scott Corning - Senior Vice President, Commercial Michael Goldstein - Chief Medical Officer Conference Call Participants Adnan Butt - Guggenheim Securities Dan Leone - Raymond James Operator Good afternoon, ladies and gentlemen, thank you for standing by. And welcome to the Ocular Therapeutix Fourth Q ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36554 Ocular Therapeutix, Inc. (Exact name of registrant as specified in its charter) Delaware 20- 5560161 (State o ...